CAH:NYSECardinal Health, Inc. Analysis

Cardinal Health is trading at $222.28, just above its 20‑day SMA of $223.64 and comfortably above the 50‑day SMA of $215.64, indicating short‑term price strength while still below the 200‑day SMA of $179.78, underscoring a longer‑term bullish bias. The RSI sits at 51.8, suggesting neutral momentum, and the MACD histogram is negative (-1.31) despite a bullish trend direction, hinting at a possible short‑term pullback within an overall uptrend. The stock respects a clear support zone near $213.58 and faces resistance around $233.60, with volume trending higher, reinforcing confidence in the upside move. Volatility is elevated at ~40% over the past 30 days, but the low beta of 0.32 points to limited market‑wide risk exposure. Fundamentals show 19% revenue growth, expanding margins, and a forward EPS of $11.58, while the PE of 31.9 exceeds the industry average of 25.4, yet the DCF‑derived fair value of $668 suggests the market is significantly undervaluing the company, translating to a 12% upside relative to current price. Dividend sustainability looks solid with a 0.92% yield, a 29% payout ratio, and strong operating cash flow. Recent analyst upgrades to “Buy” and a target median price of $255 reflect confidence in continued earnings momentum. Overall, the blend of technical support, strong cash generation, and a massive valuation gap supports a positive outlook.